CXCL3, a well-known oncogene, has been confirmed to promote pathological progression in various malignancies, such as colorectal cancer (CC), prostate cancer, breast cancer and neuroblastoma tumors [34–37]. Here, CXCL3 is linked to breast carcinoma.